4//SEC Filing
Plavsic Mark 4
Accession 0000899243-22-003447
CIK 0001434316other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:37 PM ET
Size
7.4 KB
Accession
0000899243-22-003447
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-25+53,058→ 53,058 totalExercise: $39.87Exp: 2032-01-24→ Common Stock (53,058 underlying) - Award
Common Stock
2022-01-25+33,302→ 130,842 total
Footnotes (2)
- [F1]Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2023, January 8, 2024, January 8, 2025 and January 8, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date.
- [F2]The shares subject to this option vest in 48 equal month installments beginning on February 1, 2022 such that this option will be fully exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001868719
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:37 PM ET
- Size
- 7.4 KB